Transgenic crops that produce insecticidal proteins from the bacterium *Bacillus thuringiensis* (Bt) effectively suppress some pests while causing little or no harm to most non-target organisms, including people[@b1][@b2][@b3][@b4][@b5][@b6][@b7]. In some cases, Bt crops have reduced insecticide use and increased yield and farmer profits[@b8][@b9][@b10][@b11][@b12][@b13]. These benefits have spurred an increase in the hectares planted to Bt crops from 1 million in 1996 to 76 million in 2013[@b14]. However, rapid evolution of resistance to Bt crops in several pests has reduced these benefits[@b15].

To delay pest adaptation, farmers in many countries now grow Bt crop "pyramids" that produce two or more toxins that kill the same pest, rather than first generation Bt crops that each produce a single toxin[@b15]. The rationale for such pyramids is that insects resistant to one toxin will be killed by the other toxin in the pyramid[@b15]. For example, transgenic cotton producing Bt toxins Cry1Ac and Cry2Ab is the only type of Bt cotton grown in Australia, and the predominant type of Bt cotton grown in India and the United States[@b16][@b17]. However, only first generation Bt cotton producing one toxin (Cry1Ac) is grown in China[@b18], the world\'s leading producer of cotton.

Although two-toxin Bt cotton is generally expected to be more durable than Bt cotton producing only Cry1Ac, the extent of this advantage depends on several factors[@b15][@b19][@b20]. Two factors that can diminish the durability and efficacy of two-toxin cotton are cross-resistance and antagonism between toxins. Cross-resistance occurs when selection with one toxin produces resistance to the other toxin in a pyramid[@b21]. Antagonism occurs when the mortality caused by a combination of toxins is less than the mortality expected based on results with each of the toxins tested separately[@b22].

Here we used laboratory experiments to evaluate cross-resistance and antagonism between Cry1Ac and Cry2Ab in cotton bollworm, *Helicoverpa armigera*, a major pest of cotton and other crops in Asia, Africa, and Australia[@b8]. Although Bt cotton producing Cry1Ac has remained effective against this pest in China, several studies have reported a low but significantly increasing frequency of resistance to Cry1Ac in field populations, providing an early warning of potentially more serious problems[@b18][@b23][@b24]. Because Bt cotton producing Cry1Ac and Cry2Ab could help to counter or delay resistance in China, we conducted this study to better understand responses of *H. armigera* to these toxins. Whereas many previous studies have examined the effects of selection with Cry1Ac on cross-resistance to Cry2Ab in *H. armigera*[@b18], little is known about cross-resistance of this pest to Cry1Ac caused by selection with Cry2Ab. As far as we know, this is the first study to assess the effects of interactions between Cry1Ac and Cry2Ab on their toxicity to resistant and susceptible strains of *H. armigera*. We found that antagonism occurred infrequently between these toxins, but we discovered some cross-resistance, particularly to Cry1Ac caused by selection with Cry2Ab.

Results
=======

Effects of selection with Cry1Ac, Cry2Ab, and a mixture of toxins
-----------------------------------------------------------------

We calculated the resistance ratio as the concentration of toxin killing 50% (LC~50~) of larvae for a strain divided by the LC~50~ of the same toxin for the susceptible strain 96S, which was the parent strain for all of the selected strains. Selection of the 96-1Ac strain with Cry1Ac for 102 and 125 generations, respectively, yielded resistance ratios of 3000 and 1000 for Cry1Ac, but only 1.6 and 6.8 for Cry2Ab ([Table 1](#t1){ref-type="table"}). The difference in LC~50~ values of Cry2Ab between the 96-1Ac strain and its unselected parent strain 96S was significant after 125 generations, but not after 102 generations ([Table 1](#t1){ref-type="table"}). Selection of the 96-2Ab strain with Cry2Ab for 29 generations yielded weak resistance to Cry2Ab (resistance ratio = 5.6) and strong cross-resistance to Cry1Ac (resistance ratio = 61) ([Table 1](#t1){ref-type="table"}).

Selection of the 96-Mix strain with a mixture containing Cry1Ac, a Cry2 toxin, Cry1C, and Vip3A caused significant resistance to both Cry1Ac and Cry2Ab ([Table 1](#t1){ref-type="table"}). After selection for 102 and 125 generations, respectively, the 96-Mix strain had resistance ratios of 2400 and 410 for Cry1Ac, as well as 16 and 21 for Cry2Ab ([Table 1](#t1){ref-type="table"}).

After the 96-1Ac strain had been selected for 102 generations, it was split into two sub-strains that were reared for an additional 29 generations as follows: 96-1Ac/2Ab was selected with Cry2Ab and 96-1Ac/U was reared without exposure to toxins. During the 29 generations of selection with Cry2Ab, the resistance ratio of 96-1Ac/2Ab increased for Cry2Ab from 6.8 to 34 (5-fold) and decreased for Cry1Ac from 1000 to 28 (36-fold) ([Table 1](#t1){ref-type="table"}). During the 29 generations without exposure to toxins, the resistance ratios of 96-1Ac/U decreased from 1000 to 20 (50-fold) for Cry1Ac and from 6.8 to 1.2 (6-fold) for Cry2Ab ([Table 1](#t1){ref-type="table"}). These decreases imply that, in the absence of exposure to Bt toxins, fitness was lower for resistant insects than susceptible insects.

Toxicity of mixtures of Cry1Ac and Cry2Ab to susceptible and resistant strains
------------------------------------------------------------------------------

For the susceptible parent strain 96S and each of the four resistant strains (96-1Ac, 96-Mix, 96-2Ab, and 96-1Ac/2Ab), we evaluated observed versus expected mortality for 36 combinations of Cry1Ac and Cry2Ab (six concentrations of each toxin by six concentrations of the other toxin) ([Figures 1](#f1){ref-type="fig"} and [2](#f2){ref-type="fig"}). For the susceptible 96S strain, no significant deviation from the expected independent action of the toxins occurred in 30 of 36 (83%) combinations tested ([Figures 1](#f1){ref-type="fig"} and [3](#f3){ref-type="fig"}). Four combinations (11%) had lower than expected mortality, reflecting antagonism between Cry1Ac and Cry2Ab, and only two combinations (6%) produced higher than expected mortality, indicative of synergism ([Figures 1](#f1){ref-type="fig"} and [3](#f3){ref-type="fig"}). The six combinations in which antagonism or synergism occurred all involved one of the three lowest concentrations of Cry1Ac (0.02, 0.06 or 0.18 μg toxin per cm^2^ diet).

By contrast, for each of the four resistant strains, 67 to 100% of the combinations tested showed higher than expected mortality, reflecting synergism between Cry1Ac and Cry2Ab, while all of the remaining combinations showed independent interactions (no synergism or antagonism) between the two toxins ([Figures 2](#f2){ref-type="fig"} and [3](#f3){ref-type="fig"}).

Discussion
==========

The results show that against a susceptible strain of *H. armigera*, antagonism between Cry1Ac and Cry2Ab occurred in only 11% (4 of 36) of combinations tested, and only at relatively low concentrations of Cry1Ac ([Figures 1](#f1){ref-type="fig"} and [3](#f3){ref-type="fig"}). Moreover, against the four resistant strains studied (96-1Ac, 96-Mix, 96-2Ab, and 96-1Ac/2Ab), no antagonism occurred and synergism was seen in 67 to 100% of the combinations tested of these two toxins ([Figures 1](#f1){ref-type="fig"} and [3](#f3){ref-type="fig"}). These results suggest that antagonism would have little or no negative effect on the efficacy of a pyramid of Cry1Ac and Cry2Ab against susceptible or resistant *H. armigera*, particularly at relatively high concentrations of Cry1Ac. Field experiments with Bt cotton plants producing Cry1Ac alone, Cry2Ab alone, and both toxins would be needed to determine if the interactions between these toxins seen in our diet experiments also occur on plants in the field.

The results here show some cross-resistance between Cry1Ac and Cry2Ab in *H. armigera* that could reduce the durability of a pyramid. Although the initial 102 generations of selection of the 96-1Ac strain with Cry1Ac did not produce significant cross-resistance to Cry2Ab, an additional 23 generations of selection with Cry1Ac yielded statistically significant 6.8-fold cross-resistance to Cry2Ab ([Table 1](#t1){ref-type="table"}). This 6.8-fold cross-resistance to Cry2Ab is numerically higher than any cross-resistance to Cry2Ab caused by selection with Cry1Ac in previous studies of 12 field- and laboratory-selected strains of *H. armigera* from Australia, China and India ([Table 2](#t2){ref-type="table"}). Four of the 12 Cry1Ac-selected strains showed significant cross-resistance based on the conservative criterion of non-overlap of the 95% fiducial limits of their LC~50~ values relative to those of a susceptible strain tested in the same study (resistance ratios for Cry2Ab = 2.5, 4.2, 5.8 and 6.8, [Table 2](#t2){ref-type="table"}). Considering all 14 estimates of cross-resistance to Cry2Ab from the 12 strains, the mean resistance ratio for Cry2Ab is 1.3, which is significantly greater than the mean resistance ratio of 1.0 expected in the absence of cross-resistance (paired t-test, df = 13, t = 2.5, P = 0.025). These results indicate that on average, selection with Cry1Ac caused minor cross-resistance to Cry2Ab in *H. armigera*.

Selection of the 96-2Ab strain (derived from the susceptible 96S strain) with Cry2Ab caused 61-fold cross-resistance to Cry1Ac ([Table 1](#t1){ref-type="table"}). Thus, the results here provide evidence of asymmetrical cross-resistance between Cry1Ac and Cry2Ab in *H. armigera*, similar to the pattern observed in laboratory strains of pink bollworm (*Pectinophora gossypiella*), in which selection with Cry1Ac did not cause strong cross-resistance to Cry2Ab, but selection with Cry2Ab caused strong cross-resistance to Cry1Ac[@b25]. By contrast, a strain of *H. armigera* from Australia with 9600-fold resistance to Cry2Aa did not have significant cross-resistance to Cry1Ac[@b26].

In addition, the results here show that resistance to Cry1Ac decreased by a factor of 36 (from 1000-fold to 28-fold) during 29 generations of selection with Cry2Ab ([Table 1](#t1){ref-type="table"}) in the 96-1Ac/2Ab strain, which was derived from 96S and selected with Cry1Ac followed by Cry2Ab. By comparison, resistance in the 96-1Ac/U strain decreased by a factor of 50 (from 1000-fold to 20-fold) during 29 generations without exposure to any Bt toxin ([Table 1](#t1){ref-type="table"}). After these 29 generations, the LC~50~ of Cry1Ac did not differ significantly between 96-1Ac/Cry2Ab and 96-1Ac/U, indicating that in this case, selection with Cry2Ab did not significantly increase resistance to Cry1Ac.

One potential explanation for the results with the 96-1Ac/Cry2Ab and 96-1Ac/U strains is that the 1000-fold resistance to Cry1Ac in the 96-1Ac strain was associated with a large fitness cost that was not overcome by subsequent selection with Cry2Ab. On the other hand, exposure of the 96-2Ab strain to Cry2Ab (which was initially susceptible to Cry1Ac), caused sufficient selection for cross-resistance to Cry1Ac to increase its LC~50~ of Cry1Ac by 61-fold ([Table 1](#t1){ref-type="table"}). This suggests that the fitness cost was low or nil for this relatively low level of resistance to Cry1Ac. In general, mutations conferring high levels of resistance to Bt toxins are most likely to cause fitness costs[@b27].

Additional work is needed to determine the genetic basis and mechanism of asymmetrical cross-resistance between Cry1Ac and Cry2Ab in *H. armigera* and *P. gossypiella*. In both of these insects, cross-resistance was detected between these toxins despite the finding that Cry1A toxins do not share binding sites with Cry2A toxins[@b28][@b29][@b30]. These results imply that lack of shared binding sites is necessary, but not sufficient, to infer that cross-resistance does not occur between toxins. In general, mechanisms of resistance other than reduced binding to midgut receptors can confer cross-resistance between toxins that do not share binding sites[@b31][@b32].

The increasing frequency of resistance to Cry1Ac in populations of *H. armigera* from China and cross-resistance between Cry1Ac and Cry2Ab in some strains of *H. armigera* raise concerns about potential resistance of field populations to two-toxin Bt cotton producing Cry1Ac and Cry2Ab[@b18][@b23]. In bioassays with Bt cotton leaves containing Cry1Ac and Cry2Ab, survival was 13 times higher for the Cry1Ac-selected Res-Bt strain of *H. armigera* (32%) relative to a susceptible strain (2.4%), even though this strain had only 72-fold resistance to Cry1Ac and no cross-resistance to Cry2Ab[@b33]. Similar results with *Helicoverpa zea* show that survival from neonate to adult on Bt cotton producing Cry1Ac and Cry2Ab was 11 times higher for the Cry1Ac-selected GA-R strain (6.7%) relative to its unselected parent strain (0.6%), even though resistance of GA-R relative to GA was only 10-fold to Cry1Ac and 2-fold to Cry2Ab[@b15].

Although Cry1Ac is the only Bt toxin produced by transgenic cotton grown in China, two-toxin Bt cotton producing Cry1Ac and Cry2Ab has become the predominant type of Bt cotton grown in India and the United States, and the only type of Bt cotton grown in Australia[@b16]. In China, a shift now to Bt cotton producing both Cry1Ac and Cry2Ab would probably delay evolution of resistance in *H. armigera* and in *P. gossypiella*[@b34]. However, considering the increasing frequency of resistance of *H. armigera* in China to Cry1Ac and the risk of an associated increase in survival on Bt cotton producing Cry1Ac and Cry2Ab discussed above, switching to Bt cotton producing a toxin other than Cry1Ac or Cry2Ab could be particularly useful in China[@b23]. For example, three-toxin Bt cotton producing Vip3Aa, Cry1Ac and Cry2Ab is expected to be available commercially in a few years[@b35]. Vip3Aa could be especially valuable in China because of the lack of cross-resistance in *H. armigera* between this toxin and either Cry1Ac or Cry2Ab[@b35][@b36]. However, *H. armigera* can adapt to Vip3A[@b34]. In China, the high proportion of non-Bt host plants for *H. armigera* other than cotton, including corn and soybean, provides a "natural refuge" for susceptible insects and helps to slow evolution of resistance[@b8][@b37]. In addition to increasing the number and diversity of toxins in Bt cotton, integration of Bt cotton with other control tactics could help to delay resistance and provide a more sustainable pest management system[@b10][@b18].

Methods
=======

Bt Toxins
---------

We obtained Cry1Ac protoxin from the native *Bacillus thuringiensis* (Bt) HD73 strain and Cry2Ab protoxin from the engineered HD73^−^ strain containing the *cry2Ab* gene. Both strains were kindly supplied by Biotechnology Research Laboratory, Institute of Plant Protection, Chinese Academy of Agricultural Sciences. The Bt strains were grown at 30°C in peptone-beef extract (PB) medium (0.5% peptone and 0.3% beef extract)[@b38] until 50% of the crystal was released. Protoxins were extracted according to previously published methods[@b39]. Because Cry2Ab protoxin was produced as an inclusion rather than a pure crystal, we added 5 min of sonication (Noise Isolating Tamber, Ningbo Scientz Biotechnology Co., LTD) after the inclusion was dissolved in 1 M NaCl. Activated toxins were prepared and purified as described previously[@b40]. The concentrations of Cry1Ac and Cry2Ab protoxins were estimated on SDS--PAGE with a set of known BSA solutions as standards[@b41].

Insect Strains
--------------

All strains were reared on an artificial diet at 27 ± 1°C, 60 ± 10% relative humidity, and a photoperiod of 14 light:10 dark. To promote the long-term success of the strains, we reared at least 10,000 neonates and 500 pupae for each strain in most generations.

We used one susceptible strain (96S) and five resistant strains of *H. armigera* derived from 96S: 96-1Ac, 96-Mix, 96-2Ab, 96-1Ac/2Ab, and 96-1Ac/U. The name of each of the five resistant strains begins with 96- to emphasize that 96S was their parent strain, while the characters that follow indicate the selection regime. 96S was started with 20 pairs of adults collected in 1996 in Xinxiang County, Henan Province of China from conventional cotton that had been treated a few times yearly with Bt sprays[@b42]. 96S was reared in the laboratory for 160 generations without exposure to Bt toxins.

Each resistant strain was selected at progressively increasing toxin concentrations incorporated in diet so that about 20% of the selected neonates pupated in each selected generation[@b42]. The 96-1Ac strain (previously called BtR[@b42][@b43]) was selected for the first 60 generations with solubilized Cry1Ac protoxin[@b42] and in subsequent generations with MVPII, a liquid formulation containing Cry1Ac protoxin encapsulated in *Pseudomonas fluorescens*[@b44]. To minimize differences between 96S and 96-1Ac that are unrelated to resistance, these two strains were crossed in generations 27, 49, 69 and 87[@b42]. Based on growth inhibition bioassays in which Cry1Ac was incorporated in diet, the resistance ratio for 96-1Ac relative to 96S was reported previously as 170 in generation 16, 210 in generation 34, and 2900 in generation 87[@b42]. The 96-Mix strain (previously called BtI[@b43]) was selected with a mixture of Bt toxins (Cry1Ac, Cry2, Cry1C, and Vip3A) in technical powder (32,000 IU per mg, Wuhan Kernel Bio-tech Co., Ltd. Wuhan, China).

Starting in March 2008, three strains were initiated and reared for 29 generations as follows: The 96-2Ab strain was derived from 96S and selected with Cry2Ab. After 96-1Ac had been selected with Cry1Ac for 125 generations, two strains were derived from 96-1Ac: 96-1Ac/2Ab was selected with Cry2Ab and 96-1Ac/U was reared without exposure to Cry1Ac.

Bioassays
---------

We used diet overlay bioassays[@b45] to evaluate larval responses to Bt toxins singly and in combinations. We dispensed 1.0 mL of diet in each well of 24-well plates (TianJin Xiangyushun Co., TianJin, China). After the diet solidified, 60 µL of a dilution containing the desired concentration of one or more protoxins in 50 mM pH 10.0 Na~2~CO~3~ was overlaid on the diet surface of each well. For controls, 60 µL of 50 mM pH 10.0 Na~2~CO~3~ was overlaid on the diet surface of each well. After the diet was air-dried, one neonate that had hatched within 6 h was transferred onto the diet surface of each well. The bioassay plates were held at 27 ± 1°C, 60 ± 10% RH, and a photoperiod of 14L:10D. For each concentration of each treatment (single toxin, combination, or control), we conducted three replicates (24 neonates per plate X 3 replicates = 72 neonates total per concentration for each treatment). After 7 days, dead insects and those that were first instars were scored as dead.

We used at least five toxin concentrations to evaluate the LC~50~ values of Cry1Ac and Cry2Ab for each of the five strains ([Table 1](#t1){ref-type="table"}). To evaluate interactions between Cry1Ac and Cry2Ab, we tested each of the five strains at six concentrations (0.02, 0.06, 0.18, 0.53, 1.59, and 4.76 μg protoxin per cm^2^) of Cry1Ac and Cry2Ab alone as well as all 36 combinations of the six concentrations of the two toxins (6 concentrations of Cry1Ac X 6 concentrations of Cry2Ab, [Figure 1](#f1){ref-type="fig"}). Experiments were done in August 2010 for 96S, 96-Mix and 96-1Ac; and in November 2010 for 96-2Ab and 96-1Ac/2Ab.

Statistical Analysis
--------------------

We used probit analysis (Polo-Plus, LeOra Software) to calculate the toxin concentration causing 50% mortality (LC~50~) and its 95% fiducial limits (FL), We calculated resistance ratios as the LC~50~ of a strain divided by the LC~50~ of the susceptible (96S) strain.

To evaluate interactions between Cry1Ac and Cry2Ab, we first calculated the expected mortality for each combination of the two toxins using the following formula: [@b22]where S~(Cry1Ac)OBS~ is the observed proportion of larvae that survived exposure to Cry1Ac, S~(Cry2Ab)OBS~ is the observed proportion of larvae that survived exposure to Cry2Ab, and S~(Cry1Ac)OBS~ × S~(Cry2Ab)OBS~ is the proportion of larvae expected to survive exposure to a combination of Cry1Ac and Cry2Ab. To calculate excepted mortalities, we first calculated the observed adjusted survival for each toxin test singly as survival on treated diet divided by survival on untreated diet (control). All of the results reported for treated diet are based on adjusted survival. The differences of expected and observed mortalities of each combination were compared with Student\'s t-test.
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![Observed versus expected mortality caused by combinations of Cry1Ac and Cry2Ab against the susceptible 96S strain of *H. armigera.*\
The concentrations (μg/cm^2^) of Cry1Ac and Cry2Ab in each combination are indicated below the x-axis. Black bars show observed mortality and white bars show expected mortality. Significant differences between observed and expected mortality are indicated with asterisks (\*: P \< 0.05 and \*\*: P \< 0.01 based on t-tests).](srep07714-f1){#f1}

![Observed versus expected mortality caused by combinations of Cry1Ac and Cry2Ab against four resistant strains of *H. armigera* (96-Cry1Ac, 96-Mix, 96-Cry2Ab, and 96-Cry1Ac/Cry2Ab).\
The concentrations of Cry1Ac and Cry2Ab in each combination are indicated below the x-axis in μg protoxin per cm^2^ diet. Black bars show observed mortality and white bars show expected mortality. Significant differences between observed and expected mortality are indicated with asterisks (\*: P \< 0.05 and \*\*: P \< 0.01 based on t-tests).](srep07714-f2){#f2}

![Interactions between Cry1Ac and Cry2Ab against susceptible and resistant strains of *H. armigera*.\
We tested 36 combinations of Cry1Ac and Cry2Ab against each of the five strains. The height of each bar indicates the percentage of the 36 combinations that yielded a particular type of interaction (antagonistic, independent, or synergistic). Asterisks indicate 0%.](srep07714-f3){#f3}

###### Resistance and cross-resistance to Cry1Ac and Cry2Ab in *H. armigera*

  Strain        Gen.[a](#t1-fn1){ref-type="fn"}   Cry1Ac LC~50~ (95% FL)[b](#t1-fn2){ref-type="fn"}   RR[c](#t1-fn3){ref-type="fn"}             Cry2Ab LC~50~ (95% FL)              RR[c](#t1-fn3){ref-type="fn"}
  ------------ --------------------------------- --------------------------------------------------- ------------------------------- --------------------------------------------- -------------------------------
  March 2008                                                                                                                                                                                       
  96S                         132                               0.0330 (0.016--0.057)                              1.0                            0.180 (0.094--0.31)                            1.0
  96-1Ac                      102                    97.9 (48--170)[\*](#t1-fn5){ref-type="fn"}                   3000                            0.290 (0.16--0.50)                             1.6
  96-Mix                      102                    79.5 (35--150)[\*](#t1-fn5){ref-type="fn"}                   2400                2.83 (1.1--39)[\*](#t1-fn5){ref-type="fn"}                 16
  Aug. 2010                                                                                                                                                                                        
  96S                         160                               0.0280 (0.010--0.061)                              1.0                            0.386 (0.23--0.57)                             1.0
  96-1Ac                      125                          29.4[d](#t1-fn4){ref-type="fn"}                        1000                2.64 (1.7--4.1)[\*](#t1-fn5){ref-type="fn"}                6.8
  96-Mix                      125                    11.4 (5.8--89)[\*](#t1-fn5){ref-type="fn"}                    410                8.03 (4.4--75)[\*](#t1-fn5){ref-type="fn"}                 21
  Nov. 2010                                                                                                                                                                                        
  96-2Ab                      29                    1.72 (0.97--2.8)[\*](#t1-fn5){ref-type="fn"}                   61                 2.15 (1.3--3.5)[\*](#t1-fn5){ref-type="fn"}                5.6
  96-1Ac/2Ab                  29                    0.793 (0.52--1.2)[\*](#t1-fn5){ref-type="fn"}                  28                 13.1 (5.5--85)[\*](#t1-fn5){ref-type="fn"}                 34
  96-1Ac/U                    29                   0.572 (0.055--0.15)[\*](#t1-fn5){ref-type="fn"}                 20                              0.477 (0.18--1.2)                             1.2

^a^Generation.

^b^Concentration killing 50% with 95% fiducial limits in parentheses, units are μg toxin per cm^2^diet.

^c^Resistance ratio, the LC~50~ for a strain divided by the LC~50~ for 96S for the same toxin in the same year.

^d^The highest concentration tested (4.76 μg Cry1Ac per cm^2^diet) caused a mean of 27.8% mortality and the probit analysis did not yield 95% fiducial limits for the LC~50~.

\*Significantly different from 96S tested in the same year based on non-overlap of 95% fiducial limits of the LC~50~ values.

###### Resistance to Cry1Ac and cross-resistance to Cry2Ab in Cry1Ac-selected strains of *H. armigera*

  Country                                                   Location                Year[a](#t2-fn2){ref-type="fn"}                Strain                 Cry1Ac RR[b](#t2-fn3){ref-type="fn"}    Cry2Ab RR[b](#t2-fn3){ref-type="fn"}    Reference
  ------------------------------------------- ------------------------------------ --------------------------------- ----------------------------------- -------------------------------------- ---------------------------------------- ------------
  Lab-selected                                                                                                                                                                                                                                 
  Australia                                                 Multiple                 NA[c](#t2-fn4){ref-type="fn"}                   BX                                    44                                     1.4                       [@b46]
  China                                                      Anyang                              2011                                AY2                                  1200                      5.8[\*](#t2-fn1){ref-type="fn"}         [@b18]
  China                                        Gaoyang[d](#t2-fn5){ref-type="fn"}                2001                              SCD-r1                                 440                                     1.2                       [@b47]
  China                                                     Gaoyang                              2001                               GYBT                                  560                        1.4[e](#t2-fn6){ref-type="fn"}         [@b48]
  China                                                     Langfang                             2000                              LFR~10~                   250[f](#t2-fn7){ref-type="fn"}          1.0[f](#t2-fn7){ref-type="fn"}         [@b49]
  China                                                     Qiuxian                              2011                                QX7                                  450                       4.2[\*](#t2-fn1){ref-type="fn"}         [@b18]
  China                                                      Xiajin                              2009                              XJ-r15                                 140                                     1.4                       [@b50]
  China                                                     Xinxiang                             1996                 96-1Ac[g](#t2-fn8){ref-type="fn"}     3000[f](#t2-fn7){ref-type="fn"}       1.1 (F75)[f](#t2-fn7){ref-type="fn"}      [@b49]
  China                                                     Xinxiang                             1996                              96-1Ac                                 3000                                 1.6 (F102)                 This paper
  China                                                     Xinxiang                             1996                              96-1Ac                                 1000                   6.8[\*](#t2-fn1){ref-type="fn"} (F125)   This paper
  India                                                      Akola                                NA                              Cry1Ac-r                                 72                                     1.1                       [@b33]
  Field-selected[h](#t2-fn9){ref-type="fn"}                                                                                                                                                                                                    
  China                                                      Anyang                              2010                                Ay                                    16                       2.5[\*](#t2-fn1){ref-type="fn"}         [@b23]
  China                                                     Nanyang                              2010                                Ny                                   6.0                                     0.9                       [@b23]
  China                                                      Xiajin                              2010                                Xj                                   8.7                                     1.7                       [@b23]

\*Significant cross-resistance to Cry2Ab based on no overlap between the 95% fiducial limits for the LC~50~ of the Cry1Ac-selected strain and a susceptible strain.

^a^The year when insects were sampled from the field to start the strain.

^b^Resistance ratio, LC~50~ of Cry1Ac (or Cry2Ab) for the resistant strain divided by LC~50~ of Cry1Ac (or Cry2Ab) for a susceptible strain.

^c^Not available.

^d^The r1 allele from GYBT was introduced by repeated crossing and selection into the susceptible SCD strain.

^e^Based on Cry2Aa, which is similar to Cry2Ab.

^f^Based on concentration of toxin causing 50% weight loss (WLC~50~) of the resistant strain divided by WLC~50~ of susceptible strain 96S.

^g^BtR (the strain name used in the reference cited) is the same strain as 96-1Ac, data are from generation F75.

^h^Three strains from northern China (Ay, Ny, Xj) had been exposed extensively to Bt cotton producing Cry1Ac and had significant resistance to both Cry1Ac protoxin and activated toxin relative to the susceptible field strain from Shawan in northwest China that had little exposure to Bt cotton; RR values are for protoxin.
